Additionally, the treatment with SG-1002 upregulated the vascular endothelial growth factor (VEGF), protein kinase B (Akt), endothelial NO synthase, NO and cGMP pathway, and attenuated mitochondrial respiratory dysfunction and oxidative stress induced by TAC. This evidence concerns the gene VEGFA and persistent truncus arteriosus.